Monday, October 21, 2019

Alembic gets USFDA nod for ointment to treat skin disease

Alembic gets USFDA nod for ointment to treat skin disease The approval by the US Food and Drug Administration (USFDA) is for Clobetasol Propionate topical solution USP, 0.05 per cent, which is therapeutically equivalent to the reference listed drug product Temovate Topical Solution, 0.05 per cent, of Fougera Pharmaceuticals Inc, the company said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/32Fw2GI
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Global Market Today: Asian stocks hit record highs, oil heads for weekly loss

Asian stocks reached a record high, fueled by optimism that the reopening of the Strait of Hormuz will normalize oil flows and ease inflatio...